News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
282 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21065)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (2)
2 (8)
3 (239)
4 (237)
5 (215)
6 (254)
7 (91)
8 (4)
9 (4)
10 (258)
11 (248)
12 (223)
13 (237)
14 (120)
15 (9)
17 (67)
18 (307)
19 (282)
20 (283)
21 (121)
22 (2)
23 (8)
24 (291)
25 (323)
26 (288)
27 (305)
28 (141)
29 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
23
24
25
26
27
28
29
Business
Virginia Catalyst Strives to Advance Life Sciences in the State
Virginia, which is part of the BioSpace Hotbed region known as BioCapital, is home to an $8 billion biopharma market that employs more than 26,545 people.
February 19, 2020
·
3 min read
·
Alex Keown
Yaravirus: Something New, Weird and Unknown
It was discovered in Lake Pampulha, an artificial lake in Belo Horizonte, a city in Brazil, and infects amoeba.
February 19, 2020
·
4 min read
·
Mark Terry
Policy
Government Probe into Generics Price-Fixing Scheme Nabs Fourth Executive
Hector Armando Kellum, a former senior executive with the Novartis subsidiary Sandoz, pleaded guilty for his role in a price-fixing scheme for generic drugs developed by his company.
February 19, 2020
·
2 min read
·
Alex Keown
Policy
FDA Rejects Merck’s 6-Week Dosing Schedule for Keytruda
It doesn’t happen that often, but Merck’s checkpoint inhibitor Keytruda received a rejection from the U.S. Food and Drug Administration.
February 19, 2020
·
3 min read
·
Mark Terry
Drug Development
Five Prime Asset Paired with Opdivo Flunks Mid-Stage Pancreatic Cancer Trial
The Phase II trial did not meet its primary endpoint.
February 19, 2020
·
2 min read
·
Alex Keown
Policy
PixarBio Founder Sentenced to 7 Years in Prison for Defrauding Investors
Frank Reynolds, the founder and chief executive officer of PixarBio, was also ordered to repay $7.5 million to investors who backed the company’s non-opioid painkiller, NeuroRelease.
February 19, 2020
·
2 min read
·
Alex Keown
Business
Sanofi to Work with U.S. Government on Coronavirus (COVID-19) Vaccine
To date, there are more than 72,000 confirmed and suspected cases of COVID-19 and 1,023 deaths from COVID-19, most in mainland China.
February 19, 2020
·
3 min read
·
Mark Terry
Job Trends
Audentes to Build $109 Million Gene Therapy Factory in North Carolina
It is planned to go into operation in 2021, and is expected to create more than 200 new jobs in Lee County, North Carolina.
February 19, 2020
·
3 min read
·
Mark Terry
Policy
FDA Grants Priority Review to Genentech’s Tecentriq Monotherapy as First-line Treatment of Certain People With Advanced Non-small Cell Lung Cancer
Genentech announced that the U.S. Food and Drug Administration has accepted the company’s supplemental Biologics License Application and granted Priority Review for Tecentriq® as a first-line monotherapy for people with advanced non-squamous and squamous non-small cell lung cancer without EGFR or ALK mutations with high PD-L1 expression, as determined by PD-L1 biomarker testing.
February 19, 2020
·
10 min read
Large UK Healthcare Provider Prolongs its Radiology Imaging Contract With Sectra and Consolidates its Systems
International medical imaging IT and cybersecurity company Sectra has received an order for its radiology imaging solution from the British SWASH consortium of NHS Trusts.
February 19, 2020
·
3 min read
1 of 29
Next